A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Adefovir or Entecavir in Patients With HBeAg-Positive Chronic Hepatitis B
Clinical trial NCT00922207 · COMPLETED
Trial details
- NCT number
- NCT00922207
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-07
- Primary completion
- 2014-09-29
- Enrollment
- 280
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.